BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1365488)

  • 1. Droxicam: a pharmacological and clinical review of a new NSAID.
    Jané F; Rodríguez de la Serna A
    Eur J Rheumatol Inflamm; 1991; 11(4):3-9. PubMed ID: 1365488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic activity, clinical and gastric tolerance of 20mg daily dose of droxicam in comparison with piroxicam in patients with degenerative joint disease.
    Schüetz E; Sánchez J; García-Barbal J; Sarti JF; Reuter C; Harrison FJ
    Eur J Rheumatol Inflamm; 1991; 11(4):21-8. PubMed ID: 1365486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events with droxicam in the early clinical trials.
    Sánchez J; Bartlett A; Costa A; Estruch J; Estiarte R; Soucheiron C
    Eur J Rheumatol Inflamm; 1991; 11(4):50-8. PubMed ID: 1365491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical trial comparing a new NSAID (droxicam) and piroxicam in spinal osteoarthritis.
    Bohl D; Gausmann H; Vorberg G; Sánchez J; García-Barbal R; Sarti JF; Harrison FJ
    Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):416-9. PubMed ID: 2258250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative double-blind study of droxicam (new NSAID) versus indomethacin in rheumatoid arthritis.
    Rodríguez-de-la-Serna A; Geli-Ferrer C; Diaz-López C; Sánchez-García J
    Eur J Rheumatol Inflamm; 1991; 11(4):35-44. PubMed ID: 1365489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of the multiple dose pharmacokinetics and the tolerance of a new NSAID (droxicam) versus piroxicam in healthy volunteers.
    Martínez L; Sánchez J; Roser R; García-Barbal J; Bartlett A; Estruch J; Sagarra R; Puig S; Costa A
    Methods Find Exp Clin Pharmacol; 1988 Nov; 10(11):729-37. PubMed ID: 3221746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A new non-steroidal anti-inflammatory drug pirprofen (rengasil) in the treatment of rheumatoid arthritis and osteoarthrosis].
    Sigidin IaA; Pokryshkin VI
    Ter Arkh; 1987; 59(4):73-6. PubMed ID: 2954253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of droxicam, a new non-steroidal anti-inflammatory agent.
    Farré AJ; Colombo M; Fort M; Gutiérrez B; Rodríguez L; Roser R
    Methods Find Exp Clin Pharmacol; 1986 Jul; 8(7):407-22. PubMed ID: 3489870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Report of a controlled clinical trial of a new synthetic drug, parsalmide, in rheumatic arthropathies (inflammatory and degenerative)].
    Sanguinetti CM; Bonifazi F
    Minerva Med; 1976 Oct; 67(52):3391-5. PubMed ID: 792738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of non-steroidal antirheumatic drug-induced gastrointestinal lesions with misoprostol].
    Bach GL; Stock KP; Hüdepohl M
    Z Rheumatol; 1991; 50(3):175-80. PubMed ID: 1927064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of and tolerance to a new NSAID in the treatment of arthrosis: droxicam. Randomized study versus tenoxicam].
    Chevallard M; Venegoni C; Colombo B
    Minerva Med; 1993 Mar; 84(3):125-30. PubMed ID: 8492964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of arthritis.
    Kellick KA; Martins-Richards J; Chow C
    Lippincotts Prim Care Pract; 1998; 2(1):66-80. PubMed ID: 9451200
    [No Abstract]   [Full Text] [Related]  

  • 14. Diclofenac/misoprostol: the European clinical experience.
    McKenna F
    J Rheumatol Suppl; 1998 May; 51():21-30. PubMed ID: 9596551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misoprostol prevents NSAID-induced gastroduodenal lesions in patients with osteoarthritis and rheumatoid arthritis.
    Saggioro A; Alvisi V; Blasi A; Dobrilla G; Fioravanti A; Marcolongo R
    Ital J Gastroenterol; 1991; 23(3):119-23. PubMed ID: 1742504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil).
    Sontag SJ; Schnell TG; Budiman-Mak E; Adelman K; Fleischmann R; Cohen S; Roth SH; Ipe D; Schwartz KE
    Am J Gastroenterol; 1994 Jul; 89(7):1014-20. PubMed ID: 8017358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaprozin: a new NSAID.
    al-Faks MA; Pugh MC
    Orthop Rev; 1992 May; 21(5):558, 560-3. PubMed ID: 1603605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of 5 analgesics in patients with rheumatoid arthritis and osteoarthritis.
    Brooks PM; Dougan MA; Mugford S; Meffin E
    J Rheumatol; 1982; 9(5):723-6. PubMed ID: 6983578
    [No Abstract]   [Full Text] [Related]  

  • 19. Acetaminophen or NSAIDs for the treatment of osteoarthritis.
    Bannwarth B
    Best Pract Res Clin Rheumatol; 2006 Feb; 20(1):117-29. PubMed ID: 16483911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double blind, placebo controlled trial on the cytoprotective effect of misoprostol in subjects with rheumatoid arthritis, osteoarthritis and seronegative spondarthropathy on NSAIDs.
    Chandrasekaran AN; Sambandam PR; Lal HM; Ramakrishnan S; Porkodi R; Krishnamurthy V; Achutan K
    J Assoc Physicians India; 1991 Dec; 39(12):919-21. PubMed ID: 1816217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.